Teleflex (NYSE:TFX) Sets New 1-Year Low – Here’s Why

Teleflex Incorporated (NYSE:TFX) reached a new 52-week low on Thursday . The company traded as low as $103.97 and last traded at $104.60, with a volume of 515526 shares trading hands. The stock had previously closed at $124.75.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the stock. Zacks Research lowered shares of Teleflex from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 30th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Teleflex in a research note on Wednesday, October 8th. Royal Bank Of Canada cut their target price on Teleflex from $135.00 to $120.00 and set a “sector perform” rating for the company in a research report on Friday. Wall Street Zen lowered Teleflex from a “strong-buy” rating to a “buy” rating in a research note on Monday, September 15th. Finally, Wells Fargo & Company reduced their target price on shares of Teleflex from $131.00 to $114.00 and set an “equal weight” rating on the stock in a research note on Friday. One research analyst has rated the stock with a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Reduce” and a consensus target price of $137.00.

Teleflex Stock Performance

The stock has a market cap of $4.83 billion, a price-to-earnings ratio of 25.74, a P/E/G ratio of 1.79 and a beta of 1.05. The company has a current ratio of 2.41, a quick ratio of 1.44 and a debt-to-equity ratio of 0.42. The firm has a fifty day simple moving average of $125.66 and a 200-day simple moving average of $123.13.

Teleflex (NYSE:TFX) last posted its quarterly earnings results on Thursday, November 6th. The medical technology company reported $3.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.38 by $0.29. The business had revenue of $892.90 million for the quarter, compared to analysts’ expectations of $892.79 million. Teleflex had a return on equity of 15.08% and a net margin of 6.31%.The firm’s quarterly revenue was up 19.4% compared to the same quarter last year. During the same quarter last year, the business earned $3.49 earnings per share. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. Analysts forecast that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 15th. Shareholders of record on Friday, November 14th will be issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date of this dividend is Friday, November 14th. Teleflex’s payout ratio is currently -18.50%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Pzena Investment Management LLC increased its holdings in Teleflex by 8.8% in the third quarter. Pzena Investment Management LLC now owns 387,483 shares of the medical technology company’s stock valued at $47,412,000 after purchasing an additional 31,376 shares during the last quarter. Heartland Advisors Inc. grew its position in shares of Teleflex by 200.0% during the 3rd quarter. Heartland Advisors Inc. now owns 150,000 shares of the medical technology company’s stock worth $18,354,000 after buying an additional 100,000 shares during the period. Rothschild Investment LLC increased its stake in shares of Teleflex by 15,323.5% in the 3rd quarter. Rothschild Investment LLC now owns 2,622 shares of the medical technology company’s stock valued at $321,000 after acquiring an additional 2,605 shares during the last quarter. Skandinaviska Enskilda Banken AB publ bought a new stake in shares of Teleflex in the 3rd quarter valued at about $349,000. Finally, Fifth Third Bancorp raised its position in shares of Teleflex by 7.8% in the 3rd quarter. Fifth Third Bancorp now owns 2,083 shares of the medical technology company’s stock valued at $255,000 after acquiring an additional 151 shares during the period. 95.62% of the stock is currently owned by institutional investors.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.